|5Feb 14, 9:32 PM ET

Hoberman Kenneth 5

5 · STEMLINE THERAPEUTICS INC · Filed Feb 14, 2020

Insider Transaction Report

Form 5
Period: 2019-06-12
Hoberman Kenneth
Chief Operating Officer
Transactions
  • Gift

    Stock Options (right to buy)

    2019-06-1218,0700 total
    Exercise: $2.92Exp: 2021-03-08Common Stock (18,070 underlying)
  • Gift

    Stock Options (right to buy)

    2019-06-1218,0700 total
    Exercise: $2.92From: 2013-01-29Exp: 2021-03-08Common Stock (18,070 underlying)
  • Gift

    Stock Options (right to buy)

    2019-06-1297,5800 total
    Exercise: $3.30Exp: 2022-03-09Common Stock (97,580 underlying)
  • Gift

    Stock Options (right to buy)

    2019-06-1275,0000 total
    Exercise: $5.77Exp: 2026-01-07Common Stock (75,000 underlying)
  • Gift

    Stock Options (right to buy)

    2019-06-12132,1760 total
    Exercise: $4.12Exp: 2026-02-24Common Stock (132,176 underlying)
Footnotes (4)
  • [F1]On June 12, 2019, options to purchase shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Hoberman's minor children. Mr. Hoberman is not a trustee of the trust and has no investment control over the securities held by the trust.
  • [F2]Represents options to purchase shares of common stock that vested 25% per year on each of the first four anniversaries of the grant date. All options have a 10-year life.
  • [F3]Represents options to purchase shares of common stock that vested 25% on the first anniversary and the remaining 75% vested quarterly over a three-year period.
  • [F4]Represents options to purchase shares of common stock that vested in three equal installments on each of the first three anniversaries of the January 7, 2016 grant date.

Documents

1 file
  • 5
    a5.xmlPrimary

    5